{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Current Practices in Tranexamic Acid Administration for Pediatric Trauma Patients in the United States

Activity Steps

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Recognize the parameters for the use of TXA in treating hemorrhage in pediatric trauma patients.
  2. Identify the results of the authors' study of current practices for tranexamic acid administration that could lend insight when caring for pediatric trauma patients.
Price: $21.95

Credits:

  • ANCC 1.5 CH / 1.0 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Pharmacology Hours







Test Code: JTN0121A
Published: Jan/Feb 2021
Expires: 12/2/2022
Required Passing Score: 7/10 (70%)
Authors: Brian Cornelius, DNP, CRNA, NRP; Quinn Cummings, MD; Mathieu Assercq, MD; Erin Rizzo, MD; Sonja Gennuso, MD; Angela Cornelius, MD, FACEP
Specialties: Emergency, Pediatrics, Trauma